Could a simple mask help cancer patients avoid a breathing tube?
NCT ID NCT02464696
First seen Jun 26, 2026 · Last updated Sep 15, 2026 · Updated 3 times
Summary
This study tests whether a non-invasive ventilation mask (NIPPV) can reduce the need for intubation in cancer patients with respiratory failure. Researchers will compare NIPPV plus standard oxygen therapy to standard oxygen therapy alone in 256 participants. The goal is to see if the mask improves oxygen levels and reduces shortness of breath, potentially avoiding the risks of a breathing tube.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Methylprednisolone (a steroid) and non-invasive positive pressure ventilation (NIPPV) via a mask
- What this could lead to
- If it works, this could offer a less invasive way to support breathing in cancer patients with respiratory failure, potentially avoiding the need for a breathing tube.
- What could go wrong
- This is an early-stage trial with 256 participants, so results may not apply to all patients. The intervention may not reduce intubation rates and carries risks like mask discomfort or lung injury.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 256 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2015
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Partial pressure of arterial oxygen (PaO2):fraction of inspired oxygen (FiO2) ratio =\< 300 mmHg OR a peripheral capillary oxygen saturation (SaO2):FiO2 =\< 357 * Have a diagnosed malignancy * Chest radiograph or computed tomography (CT) scan within =\< 3 months prior to study enrollment rules out primary or metastatic malignancy in the lungs or pleural space as a significant cause of respiratory insufficiency * Probability of survival is at least 6 months Exclusion Criteria: * Presence of do not resuscitate (DNR)/do not intubate (DNI) orders at study entry * Clinical evidence of left heart failure as the main etiology for respiratory compromise * Evidence of active intrathoracic malignancy (primary or metastatic) in the lungs or pleural space that is a significant cause of respiratory insufficiency * Patients with acute chronic obstructive disease exacerbation as the primary etiology for respiratory failure * Evidence of accessory respiratory muscle use with breathing * Shock (need for vasopressor therapy or mean arterial pressure \[MAP\] \< 60 despite fluid administration) * Oliguric acute renal failure (urine output \< 500 ml/day) unless already on hemodialysis * Patient already on NIPPV at the time of screening * pH \< 7.30 or partial pressure of carbon dioxide (pCO2) \> 50 (if available) * Fixed upper airway obstruction * Airway or facial trauma that would hinder the use of a NIPPV mask * Uncontrolled tachy or bradyarrhythmia or active myocardial ischemia defined as either: atrial fibrillation with rapid ventricular response (heart rate \[HR\] \> 120 beats per minute \[bpm\]), ventricular tachycardia or nonsustained ventricular tachycardia (any rate), supraventricular tachycardia (any rate), third degree heart block (any rate), heart rate less than 40 beats per minute (regardless of the rhythm) * Active myocardial ischemia defined as a clinical presentation at the time of screening consistent with acute coronary syndrome which includes unstable angina and electrocardiogram (EKG) changes suggestive of an either an acute ST elevation myocardial infarction (new ST elevations or new left bundle branch block) or acute non-ST elevation myocardial infarction (new ST depressions, new T wave inversions) * Glasgow Coma Scale (GCS) \< 8 or inadequate airway protective reflexes * Undrained pneumothorax/pneumomediastinum * Copious secretions (\> 20 cc's of sputum production per hour or significant hemoptysis defined as \> 100 cc's of hemoptysis in a 24 hour period * Risk for gastric aspiration (ie; ileus, esophageal or bowel obstruction, active vomiting) * Recent esophageal, gastric or bowel surgery (within 3 weeks of study enrollment) * Inability to cooperate with NIPPV * Refusal to receive NIPPV * Respiratory arrest
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hematopoietic and lymphoid cell neoplasm are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine stop GI cancers from returning?
- Can a phone app help childhood cancer survivors keep track of their health?
- Can the way we word cancer research invitations boost participation?
- A chill pill for Chemo's side effects? cooling therapy and a Blood-Flow drug take on nerve pain
- Wearable tech could spot Post-Surgery problems early
- Can an AI chatbot ease the aftermath of cancer?